Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591044 | SCV000706683 | uncertain significance | not provided | 2017-02-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001456835 | SCV001660624 | likely benign | Wolman disease | 2022-08-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003278933 | SCV004005718 | likely benign | Cardiovascular phenotype | 2023-04-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004543370 | SCV004758625 | likely benign | LIPA-related disorder | 2021-09-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |